Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
E

Ekachai Medical Care PCL
SET:EKH

Watchlist Manager
Ekachai Medical Care PCL
SET:EKH
Watchlist
Price: 4.94 THB -0.4%
Market Cap: ฿4.2B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
-26%
5Y
+199%
10Y
-
Investing Cash Flow
+
3Y
-118%
5Y
-692%
10Y
-
Financing Cash Flow
+
3Y
-
5Y
-2%
10Y
-

Cash Flow Statement
Ekachai Medical Care PCL

Rotate your device to view
Cash Flow Statement
Currency: THB
Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024 Mar-2025 Jun-2025 Sep-2025
Operating Cash Flow
Net Income
61
74
80
93
93
88
87
98
102
111
124
135
144
173
197
203
207
164
111
66
80
107
190
365
425
477
457
356
686
693
664
687
373
337
385
397
354
368
347
314
Depreciation & Amortization
27
27
27
26
25
26
27
28
30
31
33
35
36
37
38
41
47
54
61
67
70
72
73
74
75
75
75
75
77
79
81
84
86
88
89
89
88
88
86
85
Other Non-Cash Items
10
10
7
6
1
(1)
(4)
(7)
(9)
(9)
(8)
(6)
(5)
(5)
(4)
(3)
(2)
(2)
(1)
2
2
4
3
8
(41)
(41)
(39)
(61)
(416)
(454)
(414)
(414)
(46)
14
(34)
(26)
4
(27)
(24)
(22)
Cash Taxes Paid
19
16
17
16
16
17
15
16
16
17
19
22
23
23
28
32
33
32
24
30
30
34
37
55
56
53
80
69
70
71
60
51
51
51
56
157
157
157
164
68
Cash Interest Paid
3
2
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
Change in Working Capital
(21)
(29)
(26)
(27)
(32)
(19)
(18)
(19)
(15)
(18)
(17)
(27)
(29)
(22)
(20)
(25)
(6)
(43)
(41)
(38)
(66)
(69)
(55)
(188)
(88)
(84)
(118)
19
(18)
(23)
2
(13)
(49)
(21)
(51)
(114)
(135)
(176)
(168)
(87)
Cash from Operating Activities
77
N/A
82
+8%
87
+6%
97
+11%
88
-9%
94
+7%
92
-3%
100
+9%
108
+8%
116
+8%
132
+14%
136
+3%
145
+7%
183
+26%
210
+15%
216
+3%
245
+13%
173
-29%
130
-25%
97
-25%
85
-12%
113
+33%
212
+87%
260
+23%
372
+43%
427
+15%
374
-12%
390
+4%
328
-16%
294
-10%
334
+13%
344
+3%
363
+5%
417
+15%
389
-7%
346
-11%
310
-10%
253
-19%
240
-5%
290
+21%
Investing Cash Flow
Capital Expenditures
(9)
(9)
(10)
(18)
(25)
(45)
(54)
(69)
(107)
(114)
(113)
(115)
(133)
(166)
(219)
(236)
(223)
(169)
(124)
(102)
(80)
(83)
(82)
(83)
(83)
(92)
(97)
(99)
(94)
(96)
(94)
(87)
(83)
(85)
(82)
(83)
(249)
(283)
(343)
(435)
Other Items
0
0
0
(443)
(408)
(448)
(399)
61
(23)
20
50
35
72
111
126
195
173
143
88
45
132
132
92
35
(178)
(128)
(128)
(107)
94
(31)
(262)
(258)
(173)
(96)
401
181
(246)
31
(151)
(17)
Cash from Investing Activities
(9)
N/A
(9)
+1%
(10)
-11%
(461)
-4 460%
(433)
+6%
(493)
-14%
(453)
+8%
(8)
+98%
(130)
-1 610%
(94)
+28%
(64)
+32%
(80)
-25%
(61)
+23%
(55)
+10%
(93)
-69%
(41)
+56%
(49)
-19%
(26)
+48%
(36)
-41%
(57)
-58%
52
N/A
49
-6%
10
-80%
(48)
N/A
(262)
-443%
(221)
+16%
(226)
-2%
(207)
+8%
1
N/A
(127)
N/A
(356)
-181%
(346)
+3%
(256)
+26%
(181)
+29%
318
N/A
98
-69%
(495)
N/A
(252)
+49%
(493)
-96%
(452)
+8%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
491
491
0
0
0
0
0
0
0
0
0
0
0
20
0
0
7
(26)
(23)
(8)
29
43
40
25
288
354
0
400
112
109
0
348
348
725
561
139
97
Net Issuance of Debt
(54)
(46)
(46)
(36)
(13)
(8)
(5)
0
0
0
0
0
0
0
0
0
0
(1)
(2)
(4)
(5)
(5)
(5)
(5)
(6)
(6)
(6)
(6)
(6)
(7)
(7)
(7)
(8)
(47)
(47)
(46)
(45)
(5)
(6)
(6)
Cash Paid for Dividends
0
0
(12)
(12)
(12)
0
(60)
(60)
(60)
0
(72)
0
(72)
0
(27)
(99)
(99)
0
(126)
(126)
(126)
0
(65)
(137)
(137)
0
(150)
(78)
(78)
0
(216)
(216)
(216)
0
(213)
(430)
(430)
0
(440)
(223)
Other
0
0
0
0
0
0
3
13
13
7
4
(6)
(6)
0
0
4
4
0
(5)
(10)
(10)
0
(0)
(0)
0
0
0
0
0
0
0
0
0
40
80
124
124
84
40
(4)
Cash from Financing Activities
(54)
N/A
(46)
+14%
(58)
-26%
444
N/A
467
+5%
471
+1%
429
-9%
(47)
N/A
(47)
N/A
(53)
-13%
(68)
-29%
(78)
-14%
(78)
N/A
(72)
+8%
(99)
-38%
(95)
+4%
(75)
+21%
(76)
-2%
(114)
-50%
(133)
-17%
(167)
-26%
(164)
+2%
(79)
+52%
(113)
-44%
(101)
+11%
(104)
-3%
(132)
-27%
204
N/A
270
+32%
269
0%
177
-34%
(111)
N/A
(115)
-3%
(114)
+0%
169
N/A
(4)
N/A
373
N/A
210
-44%
(267)
N/A
(136)
+49%
Change in Cash
Net Change in Cash
14
N/A
27
+100%
19
-30%
80
+315%
122
+52%
72
-41%
68
-5%
45
-34%
(70)
N/A
(31)
+55%
(0)
+100%
(22)
-21 577%
6
N/A
56
+818%
18
-68%
80
+339%
121
+51%
71
-41%
(20)
N/A
(93)
-366%
(29)
+68%
(2)
+95%
143
N/A
98
-31%
10
-90%
102
+964%
17
-83%
386
+2 168%
599
+55%
437
-27%
155
-65%
(113)
N/A
(8)
+93%
122
N/A
876
+618%
439
-50%
188
-57%
210
+12%
(520)
N/A
(298)
+43%
Free Cash Flow
Free Cash Flow
67
N/A
73
+9%
77
+5%
79
+3%
63
-21%
49
-22%
37
-24%
31
-17%
0
-99%
2
+407%
19
+755%
21
+14%
12
-43%
17
+43%
(9)
N/A
(21)
-128%
22
N/A
4
-83%
5
+47%
(5)
N/A
6
N/A
31
+440%
129
+324%
177
+37%
289
+63%
334
+16%
277
-17%
290
+5%
235
-19%
199
-15%
240
+21%
257
+7%
280
+9%
332
+19%
307
-8%
263
-15%
62
-77%
(31)
N/A
(103)
-234%
(145)
-41%

See Also

Summary
EKH intrinsic value, competitors valuation, and company profile.
DCF Valuation
EKH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EKH stock valuation using valuation multiples.
Wall Street Estimates
EKH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EKH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 315,100+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.